Skip to Main Content
Joseph Merola, M.D.,  M.M.Sc.

Joseph Merola, M.D., M.M.Sc.

Titles and Appointments

Professor & Chair

Endowed Title
Mary Kay Inc. Distinguished Chair in Dermatology
Schools
Medical School
Departments
Dermatology | Internal Medicine | Public Health

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Joseph F. Merola, MD, MMSc, is Chair of the Department of Dermatology at UT Southwestern Medical Center, where he is Professor of Dermatology, Professor of Medicine in the Division of Rheumatology, and Professor in the Peter O’Donnell Jr. School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Board-certified in Dermatology, Internal Medicine, and Rheumatology, Dr. Merola is one of a small number of physicians nationally whose training spans these three disciplines, shaping his career at the intersection of inflammatory skin disease, systemic autoimmune disease, and musculoskeletal medicine.

    Dr. Merola is an internationally recognized clinician-scientist with expertise in psoriasis, psoriatic arthritis, connective tissue diseases including cutaneous lupus and dermatomyositis, atopic dermatitis, and complex medical dermatology. His work has focused on improving care for patients whose diseases bridge dermatology, rheumatology, and immunology, with contributions in multidisciplinary care models, clinical trial design, therapeutic development, outcome measures, epidemiology, guidelines, and patient-centered definitions of disease activity, remission, and treatment response.

    Prior to joining UT Southwestern as Chair in 2023, Dr. Merola was Vice Chair and Associate Professor in the Department of Dermatology and the Department of Medicine, Division of Rheumatology, at Harvard Medical School and Brigham and Women’s Hospital. There, he served as Vice Chair for Clinical Trials and Innovation, Founding Director of the Clinical Unit for Research Innovation and Trials, Director of the Center for Skin and Related Musculoskeletal Diseases, and Associate Program Director of the Harvard Combined Internal Medicine-Dermatology Residency Training Program.

    Dr. Merola earned his medical degree from the New York University School of Medicine and his Master of Medical Sciences degree from Harvard Medical School. He completed internship training in Internal Medicine at the Hospital of the University of Pennsylvania, Dermatology residency at New York University Medical Center, where he served as chief resident, followed by Internal Medicine residency and Rheumatology fellowship training at Brigham and Women’s Hospital.

    A major theme of Dr. Merola’s career has been building bridges across specialties to improve the recognition and management of systemic disease in dermatology and skin disease in rheumatology. Through clinical programs, research networks, educational initiatives, and international society leadership, he has helped shape the field of rheumatology-dermatology and advance collaborative approaches for psoriatic disease, lupus, dermatomyositis, eczema, and other inflammatory disorders.

    Dr. Merola has held numerous national and international leadership roles across dermatology, rheumatology, and inflammatory disease. He was elected to the Board of Directors of the American Academy of Dermatology and is the Founding President of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium. He serves on the Scientific and Medical Boards of the National Psoriasis Foundation, the Board of the International Dermatology Outcome Measures Group, the Board of the American Skin Association, and the Medical and Scientific Board of the Lupus Foundation of America. He serves as the President of the Rheumatologic Dermatology Society, Co-President of the Group for Research and

    Assessment of Psoriasis and Psoriatic Arthritis, and as a councilor for the International Eczema Council and International Psoriasis Council. He is the Past President of the Medical Dermatology Society. He has also served on multiple guideline committees, including for the American Academy of Dermatology and the American College of Rheumatology.

    Dr. Merola has authored more than 430 peer-reviewed publications in leading journals including The New England Journal of Medicine, JAMA, The Lancet, Nature Medicine, JAMA Dermatology, and the Journal of the American Academy of Dermatology. He has received numerous awards recognizing his contributions to research, education, mentorship, clinical care, and leadership, including the National Psoriasis Foundation’s Outstanding Educator Award, the Brigham and Women’s Hospital Distinguished Clinician Award, the Mass General Brigham Pillar Award in Research Leadership, and the American Skin Association Lifetime Achievement Award for Research Leadership. He was named one of Boston’s Top Doctors annually for nearly a decade, was honored at the National Psoriasis Foundation’s Commit to a Cure Gala in Dallas in 2024. In 2026 he was elected to the Association of American Physicians.

    As Chair of Dermatology at UT Southwestern, Dr. Merola is committed to supporting the department’s faculty, researchers, trainees, and staff while advancing a patient-centered mission across clinical care, education, discovery, and innovation. Under his leadership, the Department of Dermatology continues to expand its national impact as a collaborative, academically rigorous, and forward-looking program dedicated to improving patients’ lives through compassionate care, scientific discovery, and exceptional training.

  • Education
    Medical Education
    New York University School of Medicine (2005)
    Internship
    University of Pennsylvania Health System (2006), Internal Medicine
    Residency
    New York University School of Medicine (2009), Dermatology
    Residency
    Brigham and Women's Hospital (2010), Internal Medicine
    Fellowship
    Harvard Medical School/Brigham & Women's Hospital (2014), Rheumatology
  • Research Interest
    • Atopic dermatitis
    • Clinical trials, clinical trial design
    • Connective tissue disease and autoimmune skin diseases
    • Cutaneous and systemic lupus erythematosus
    • Outcome measures development, validation
    • Pharmacoepidemiology
    • Psoriasis, psoriatic arthritis
  • Publications
    Atopic dermatitis and ocular surface disorders: a United States claims-based cross-sectional study
    Asbell P, Akpek EK, Merola JF, Thyssen JP, Marcus A, Lubwama R, Ardeleanu M, Sierka D BMC Ophthalmology 2026 Dec 26
    Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study
    Scher JU, McInnes IB, Soriano ER, Merola JF, Bird P, Chandran V, Cheng E, Reynoso E, Chen W, Li M, Gensler LS, Mease PJ, Ritchlin CT Arthritis and Rheumatology 2026 Nov 78 2261-2273
    Efficacy of Apremilast in Patients with Psoriasis with Limited Skin Involvement, Including High-Impact Site Involvement: A Pooled Analysis of Six Trials
    Strober B, Lebwohl M, van de Kerkhof P, Gold LS, Merola JF, Okubo Y, Gisondi P, Zhou Z, Chaudhari S, Deignan C, Mrowietz U Dermatology and Therapy 2026 Nov 16 5839-5853
    Reply
    Merola JF, Kartman CE, Fischer P, Sun L, Cardoso A, Genovese MC, Ogdie A Arthritis and Rheumatology 2026 Nov 78 2395-2396
    Comorbidity burden across cutaneous lupus subtypes: A large US electronic health record database study
    Merola JF, Baker M, Krzywy H, Yang W, Moseley MK, Gaiha-Rohrbach J, Mirzaei F Journal of the European Academy of Dermatology and Venereology 2026 Nov 40 e931-e934
    Artificial intelligence versus experts: Navigating challenging cases in psoriatic disease
    Pérez-Chada LM, Garfinkel V, Childs BA, Bedapudi A, Woodbury M, Zhang AJ, Ruderman E, Fernandez AP, Mease P, Siegel E, Haberman R, Gladman DD, Reddy SM, Ogdie A, Scher JU, Stidham RW, Merola JF Journal of Investigative Dermatology 2026 Oct 146 2886-2889.e6
    Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
    Merola JF, Mease P, Kivitz A, Sattar N, Coates LC, Aletaha D, Kartman CE, Fischer P, Sun L, Martínez-Osuna P, Kronbergs A, Prajapati P, Cardoso A, Genovese MC, Ogdie A Arthritis and Rheumatology 2026 Oct 78 2089-2101
    A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel
    Shah M, Debusk L, Bohman MH, Rosenberg A, Burshtein J, Zakria D, Armstrong A, Boh E, Gottlieb AB, Khattri S, Litchman G, Merola J, Murina A, Lebwohl M Dermatology online journal 2026 Sep 32
    Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease
    Leite LL, Ribeiro AL, Chau J, Merola JF The Journal of rheumatology 2026 Sep 53 37-40
    Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings
    Warren RB, Gooderham M, Lain E, Bissonnette R, Huang YH, Ringuet J, Hoffmann M, Pinter A, Merola JF, Rubens JH, Fan D, Hsu MC, Li S, Yang YW, DeKlotz CM, Song EJ Journal of the European Academy of Dermatology and Venereology 2026 Sep 40 1502-1514
  • Books

    Featured 

    Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology (1st ed.)

    Garg A, Merola JF, Fitzpatrick L (2022). Springer Publishing

    Drug-induced lupus erythematosus in Clinical Management of Systemic Lupus Erythematosus (2nd ed.)

    Merola, JF (1996). Philadelphia, PA, Lippincott-Raven

  • Honors & Awards
    • Honoree National Psoriasis Foundation Gala
      (2024)
    • Distinguished Clinician Award
      Brigham and Womens Hospital, Harvard Medical School (2022)
    • Educator of the Year Award
      Winter Clinical Dermatology Conference (2022)
    • Nominee, Senior Faculty Mentorship Award / Pillars of Excellence Award
      Mass General Brigham (2022)
    • Outstanding Educator in Psoriatic Disease Award
      National Psoriasis Foundation Annual Meeting (2022)
    • Pillars of Excellence Award in Research Leadership
      Brigham and Womens Hospital (2020)
    • Boston Top Doctors
      8 Consecutive Years
    • Nominated for Multiple Teaching Awards
      Bernard Lown Award, Harvard Mentoring Award, and Charles McCabe Award
  • Professional Associations/Affiliations
    • American Academy of Dermatology
    • American College of Rheumatology
    • American Dermatological Association
    • Association of Professors of Dermatology
    • Association of Program Directors in Internal Medicine
    • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
    • International Eczema Council
    • International Psoriasis Council
    • Lupus Foundation of America
    • Medical Dermatology Society
    • National Psoriasis Foundation
    • Noah Worcester Dermatological Society
    • Psoriasis & Psoriatic Arthritis Clinics Multicenter Advancement Network
    • Rheumatologic Dermatology Society
    • Society for Investigative Dermatology